From: A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death
Cardioversion
Pacemaker
Defibrillator
Wall thinning
Heart failure
Heart transplantation
Group A (n)
2 (5.9%)
1 (2.9%)
0
Group B (n)
5 (6.8%)
4 (5.5%)
8 (11.0%)
11 (15.1%)